Antileishmanial High-Throughput Drug Screening Reveals Drug Candidates with New Scaffolds

Drugs currently available for leishmaniasis treatment often show parasite resistance, highly toxic side effects and prohibitive costs commonly incompatible with patients from the tropical endemic countries. In this sense, there is an urgent need for new drugs as a treatment solution for this neglect...

Descripción completa

Detalles Bibliográficos
Autores principales: Siqueira-Neto, Jair L., Song, Ok-Ryul, Oh, Hyunrim, Sohn, Jeong-Hun, Yang, Gyongseon, Nam, Jiyoun, Jang, Jiyeon, Cechetto, Jonathan, Lee, Chang Bok, Moon, Seunghyun, Genovesio, Auguste, Chatelain, Eric, Christophe, Thierry, Freitas-Junior, Lucio H.
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2864270/
https://www.ncbi.nlm.nih.gov/pubmed/20454559
http://dx.doi.org/10.1371/journal.pntd.0000675

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2864270/
https://www.ncbi.nlm.nih.gov/pubmed/20454559
http://dx.doi.org/10.1371/journal.pntd.0000675

Ejemplares similares